同济堂
  Investor Relations
    Directors and Executive Officers
    Corporate Governance
    Stock Information
    Financial Reports
    SEC Filings
    Events
    Analyst Coverage
    Shareholder Services
     Download Investor Kit
     IR Contact
 
  Investor Relations You are here: Home -- Investor Relations  
 
  Corporate Profile
Tongjitang Chinese Medicines Company is a vertically integrated and profitable specialty pharmaceutical company focusing on the development, manufacturing,marketing and selling of modernized traditional Chinese medicine in China. ...More>>
 
Exchange: NYSE (US Dollar)
Price: 3.81
Change: 0.01
Volume: 14850
Data as of: 3/9/2010 4:00pm
 
 
 
 
  Mar 1, 2010 Tongjitang Chinese Medicines Company to Announce Fourth Quar......
 
 
  Feb 2,2010 Tongjitang Chinese Medicines Acquires Guiyang Liquor Factory......
 
 
  Dec 23,2009 Chairman’s Script for 2009 Annual General Meeting......
 
     
 
Date Format Title
Dec 15,2009 Printer Friendly Version Presentation - Investor Conference December 2009
 
IR Contact
f
Ashley Ammon
or Christine Duan
ICR Inc.
Tel:1-203-682-8200
Email:ashley.ammon@icrinc.com; christine.duan@icrinc.com